4.8 Article

Tumor Seeding During Colonoscopy as a Possible Cause for Metachronous Colorectal Cancer

期刊

GASTROENTEROLOGY
卷 157, 期 5, 页码 1222-+

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2019.07.062

关键词

Colon Cancer; Recurrence; Metastasis; Complication

资金

  1. Sacha Swarttouw-Hijmans Foundation

向作者/读者索取更多资源

BACKGROUND AND AIMS: In patients who have undergone surgery for colorectal cancer (CRC), 3% have recurrence of (metachronous) CRC. We investigated whether tumor seeding during colonoscopy (iatrogenic implantation of tumor cells in damaged mucosa) increases risk for metachronous CRC. METHODS: In a proof of principle study, we collected data from the Dutch National Pathology Registry for patients with a diagnosis of CRC from 2013 through 2015, with a second diagnosis of CRC within 6 months to 3.5 years after surgery. We reviewed pathology reports to identify likely metachronous CRC (histologically proven adenocarcinoma located elsewhere in the colon or rectum from the surgical anastomosis). For 22 patients fulfilling the inclusion criteria, we ascribed the most likely etiology to tumor seeding when endoscopic manipulations, such as biopsies or polypectomy, occurred at the location where the metachronous tumor was subsequently detected, after endoscopic manipulation of the primary tumor. We collected clinical data from patients and compared molecular profiles of the primary and metachronous colorectal tumors using next-generation sequencing. We then examined the source of seeded tumor. We tested whether tumor cells stay behind in the working channel of the endoscope after biopsies of colorectal tumors, and whether these cells maintain viability in organoid cultures. RESULTS: In total, tumor seeding was suspected as the most likely etiology of metachronous CRC in 5 patients. Tumor tissues were available from 3 patients. An identical molecular signature was observed in the primary and metachronous colorectal tumors from all 3 patients. In 5 control cases with a different etiology of metachronous CRC, the molecular signature of the primary and metachronous tumor were completely different. Based on review of 2147 patient records, we estimated the risk of tumor seeding during colonoscopy to be 0.3%-0.6%. We demonstrated that the working channel of the colonoscope becomes contaminated with viable tumor cells during biopsy collection. Subsequent instruments introduced through this working channel also became contaminated. These cells were shown to maintain their proliferative potential. CONCLUSIONS: In an analysis of primary and secondary tumors from patients with metachronous CRC, we found that primary tumor cells might be seeded in a new location after biopsy of the primary tumor. Although our study does not eliminate other possibilities of transmission, our findings and experiments support the hypothesis that tumor seeding can occur during colonoscopy via the working channel of the endoscope. The possibility of iatrogenic seeding seems low. However, our findings compel awareness on this potentially preventable cause of metachronous CRC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018

Josanne S. de Maar, Marianne Luyendijk, Britt B. M. Suelmann, Dave E. W. van der Kruijssen, Sjoerd G. Elias, Sabine Siesling, Elsken van der Wall

Summary: This study aimed to compare characteristics and survival of patients with de novo and metachronous metastatic breast cancer. Data from the Netherlands Cancer Registry were used to categorize patients into de novo or metachronous metastatic breast cancer groups. The study found differences in clinicopathological characteristics and survival between these two groups.

BREAST CANCER RESEARCH AND TREATMENT (2023)

Article Oncology

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma

Sarah R. Verhoeff, Sjoukje F. Oosting, Sjoerd G. Elias, Suzanne C. van Es, Sophie L. Gerritse, Lindsay Angus, Sandra Heskamp, Ingrid M. E. Desar, C. Willemien Menke-van der Houven van Oordt, Astrid A. M. van der Veldt, Anne I. J. Arens, Adrienne H. Brouwers, Bertha Eisses, Peter F. A. Mulders, Otto S. Hoekstra, Gerben J. C. Zwezerijnen, Winette T. A. van der Graaf, Erik H. J. G. Aarntzen, Wim J. G. Oyen, Carla M. L. van Herpen

Summary: Patients with metastatic clear-cell renal cell carcinoma (mccRCC) with good or intermediate prognosis can consider watchful waiting (WW), especially those who meet the watch and wait (W&W) criteria of < 2 International Metastatic RCC Database Consortium criteria and <=2 metastatic sites. This study aimed to assess the predictive value of [F-18]FDG PET/CT and [Zr-89]Zr-DFO-girentuximab PET/CT for the duration of WW in patients with mccRCC.

CLINICAL CANCER RESEARCH (2023)

Article Oncology

Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis

Dave E. W. van Der Kruijssen, Auke J. S. van Der Kuil, Geraldine R. Vink, Cornelis J. A. Punt, Johannes H. W. de Wilt, Sjoerd G. Elias, Miriam Koopman

Summary: This study investigated the prognostic value of primary tumor sidedness in metastatic colorectal cancer over time and across treatment lines. Population data and prospective studies were examined to determine the time-varying nature of sidedness and its influence on prognosis. The results suggest that the prognostic value of primary tumor sidedness decreases over time and varies depending on the treatment line.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Cell Biology

Cellular polyploidy in organ homeostasis and regeneration

Juntao Fang, Alain de Bruin, Andreas Villunger, Raymond Schiffelers, Zhiyong Lei, Joost P. G. Sluijter

Summary: Polyploid cells, containing more than one set of chromosome pairs, are common in nature. They provide cells with several advantages, including increased cell size, organ growth, tissue homeostasis, and enhanced tolerance to genomic stress and apoptotic signals. This article focuses on the reasons for polyploidy, the stress responses and molecular signals involved, as well as its crucial roles in cell growth and tissue regeneration in the heart, liver, and other tissues.

PROTEIN & CELL (2023)

Article Oncology

Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma

Isabella A. J. van Duin, Sjoerd G. Elias, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Willeke A. M. Blokx, Paul J. van Diest, Tim Leiner, Joost J. C. Verhoeff, Rik J. Verheijden, Olivier J. van Not, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, John B. A. G. Haanen, Geke A. P. Hospers, Anna M. Kamphuis, Djura Piersma, Rozemarijn S. van Rijn, Astrid A. M. van Der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Marion A. M. Stevense-den Boer, Marye J. Boers-Sonderen, Ellen Kapiteijn, Karijn P. M. Suijkerbuijk

Summary: Since the introduction of BRAF(/MEK) inhibition and immune checkpoint inhibition (ICI), the prognosis of advanced melanoma has greatly improved. We investigated the relationship between time to first distant recurrence (TFDR) and patient outcomes after systemic treatment for advanced melanoma. The results showed that patients with a longer TFDR have prolonged PFS and OS, regardless of the type of treatment they received.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Chemistry, Multidisciplinary

TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery

Nazma F. Ilahibaks, Arif I. Ardisasmita, Songpu Xie, Anders Gunnarsson, Joseph Brealey, Pieter Vader, Olivier G. de Jong, Saskia de Jager, Niek Dekker, Ben Peacock, Raymond M. Schiffelers, Joost P. G. Sluijter, Zhiyong Lei

Summary: Extracellular vesicles (EVs) are being explored as biocompatible drug delivery vehicles for their ability to deliver bioactive cargo to recipient cells. However, effective methods for loading and unloading proteins inside EVs remain a challenge. In this study, we present the Technology Of Protein delivery through Extracellular Vesicles (TOP-EVs) as an efficient tool for intracellular protein delivery mediated by EVs. Our results demonstrate the versatility and potential of TOP-EVs for protein-based therapeutics in vitro and in vivo.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study

Max A. A. Ragusi, Bas H. M. van der Velden, Carla Meeuwis, Eric Tetteroo, Emile G. Coerkamp, Thiemo J. A. van Nijnatten, Frits H. Jansen, Elian J. M. Wolters-van der Ben, Lisa Jongen, Fleur van Raamt, Monique D. Dorrius, Janneke Verloop, Max A. Viergever, Ruud M. Pijnappel, Sjoerd G. Elias, Kenneth G. A. Gilhuijs

Summary: A multicenter retrospective cohort study was conducted to confirm the association between contralateral parenchymal enhancement (CPE) and long-term survival in patients with ER-positive and HER2-negative breast cancer. The study also aimed to investigate the relationship between CPE and endocrine therapy effectiveness.

RADIOLOGY (2023)

Article Medicine, General & Internal

Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial

Maaike E. Verweij, Max D. Tanaka, Chavelli M. Kensen, Uulke A. van der Heide, Corrie A. M. Marijnen, Tomas Janssen, Tineke Vijlbrief, Wilhelmina M. U. van Grevenstein, Leon M. G. Moons, Miriam Koopman, Miangela M. Lacle, Manon N. G. J. A. Braat, Myriam Chalabi, Monique Maas, Inge L. Huibregtse, Petur Snaebjornsson, Brechtje A. Grotenhuis, Remond Fijneman, Esther Consten, Apollo Pronk, Anke B. Smits, Joost T. Heikens, Hidde Eijkelenkamp, Sjoerd G. Elias, Helena M. Verkooijen, Maartje M. C. Schoenmakers, Gert J. Meijer, Martijn Intven, Femke P. Peters

Summary: This study aims to establish the maximum tolerated dose of dose-escalated short-course radiotherapy using online adaptive magnetic resonance-guided radiotherapy in patients with intermediate-risk rectal cancer. The primary endpoint is the maximum tolerated dose based on the incidence of dose-limiting toxicity. Secondary endpoints include the organ preservation rate, oncological outcomes, patient-reported quality of life, and functional outcomes.

BMJ OPEN (2023)

Article Immunology

Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer

Esther Strating, Mathijs P. P. Verhagen, Emerens Wensink, Ester Duennebach, Liza Wijler, Itziar Aranguren, Alberto Sanchez de la Cruz, Niek A. A. Peters, Joris H. H. Hageman, Mirjam M. C. van der Net, Susanne van Schelven, Jamila Laoukili, Riccardo Fodde, Jeanine Roodhart, Stefan Nierkens, Hugo Snippert, Martijn Gloerich, Inne Borel Rinkes, Sjoerd G. G. Elias, Onno Kranenburg

Summary: A co-culture model system of colon cancer organoids and cancer-associated fibroblasts (CAFs) was established, which can recapitulate the histological, biophysical, and immunosuppressive features of aggressive mesenchymal-like human colorectal cancer (CRC). This model can be used to study the mechanisms of immunosuppression and test therapeutic strategies targeting the interaction between CAFs and cancer cells. Furthermore, it can be modified to represent different colon cancer subtypes and (organ-specific) microenvironments.

FRONTIERS IN IMMUNOLOGY (2023)

Article Pharmacology & Pharmacy

Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles

Laura E. Swart, Marcel H. A. M. Fens, Anita van Oort, Piotr Waranecki, L. Daniel Mata Casimiro, David Tuk, Martijn Hendriksen, Luca van den Brink, Elizabeth Schweighart, Cor Seinen, Ryan Nelson, Anja Krippner-Heidenreich, Tom O'Toole, Raymond M. Schiffelers, Sander Kooijmans, Olaf Heidenreich

Summary: Lipid nanoparticles (LNPs) are rapidly evolving as promising delivery systems for oligonucleotides, including siRNAs. In this study, LNPs were specifically targeted to hematopoietic progenitor cells in the bone marrow using a modified tripeptide ligand. Functionalized LNPs showed improved uptake and delivery of siRNA in patient-derived leukemia cells, as well as increased accumulation and retention in the bone marrow. These findings suggest the potential of LNPs for targeted therapy in leukemia and other hematological disorders.

PHARMACEUTICS (2023)

Article Chemistry, Multidisciplinary

Levodopa-loaded nanoparticles for the treatment of Parkinson's disease

Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, Massimiliano Caiazzo, Marcel H. A. M. Fens

Summary: Parkinson's disease is characterized by degeneration of dopaminergic neurons, causing dopamine deficiency and motor symptoms. Current treatment using L-DOPA has limitations and side effects. Encapsulation of L-DOPA into nanoparticles can protect it and improve delivery to the brain, reducing required dosages and side effects. Alternative delivery methods, such as intravenous administration and transdermal delivery, enhance therapeutic effects. This review discusses recent advances and future perspectives on NP-mediated L-DOPA delivery to the brain.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Nanomedicines: An approach to treat placental insufficiency and the current challenges

C. M. van Kammen, S. J. van Woudenberg, R. Schiffelers, F. Terstappen, A. T. Lely

Summary: Preeclampsia and fetal growth restriction are pregnancy complications that can be treated with nanomedicines, which regulate drug interaction with the placenta to enhance treatment efficacy and minimize fetal exposure. Liposomes and polymeric drug delivery systems show promising results in preventing trans-placental passage of nanomedicines, while quantum dots and silicon nanoparticles have limited research in placental insufficiency syndromes. Animal studies demonstrate positive effects on maternal and fetal health, but results are influenced by various factors. Further research is needed to understand the pathophysiology of these complex diseases and ensure the safety and efficacy of nanomedicines before clinical implementation.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Gastroenterology & Hepatology

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship

Anouk M. Wijnands, Sjoerd G. Elias, Evelien Dekker, Herma H. Fidder, Frank Hoentjen, Joren R. ten Hove, P. W. Jeroen Maljaars, Andrea E. van der Meulen-de Jong, Erik Mooiweer, Renske J. Ouwehand, Bas B. L. Penning de Vries, Cyriel Y. Ponsioen, Fiona D. M. van Schaik, Bas Oldenburg

Summary: This study aimed to clarify the association between smoking and the development of colorectal neoplasia in patients with inflammatory bowel disease (IBD). The results showed that smoking was not associated with the risk of recurrent colorectal neoplasia, but an increasing number of pack-years was associated with a higher risk of recurrence.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer

Esther Strating, Anne van de Loo, Sjoerd Elias, Marnix Lam, Onno Kranenburg

PET CLINICS (2023)

Article Chemistry, Multidisciplinary

Fusogenic Coiled-Coil Peptides Enhance Lipid Nanoparticle-Mediated mRNA Delivery upon Intramyocardial Administration

Ye Zeng, Mariona Estape Senti, M. Clara I. Labonia, Panagiota Papadopoulou, Maike A. D. Brans, Inge Dokter, Marcel H. Fens, Alain van Mil, Joost P. G. Sluijter, Raymond M. Schiffelers, Pieter Vader, Alexander Kros

Summary: This study demonstrates the efficient delivery of mRNA-LNPs to difficult-to-transfect cardiomyocytes using fusogenic coiled-coil peptides. Local administration via intramyocardial injection significantly enhances mRNA delivery and protein expression. These findings have the potential to advance regenerative therapies for heart failure.

ACS NANO (2023)

暂无数据